Human Papillomavirus (HPV) Vaccination Acceptance by African-American Parents: Identifying Psychosocial Barriers
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
This will enroll 300 mothers of teenage girls and boys to identify barriers to HPV vaccination among low-income, African-American teens.
| Condition | Intervention | Phase |
|---|---|---|
|
HPV |
Behavioral: brief informational intervention to promote HPV vaccine acceptance |
Phase 2 |
| Study Type: | Interventional |
| Study Design: | Endpoint Classification: Efficacy Study Intervention Model: Single Group Assignment Masking: Open Label Primary Purpose: Prevention |
| Official Title: | HPV Vaccination Acceptance by African-American Parents: Identifying Psychosocial Barriers |
- completed vaccination with Gardasil [ Time Frame: 6 months ] [ Designated as safety issue: No ]
- assessed cross-sectionally, at time of initial enrollment [ Time Frame: assessed at time of baseline assessment ] [ Designated as safety issue: No ]
| Estimated Enrollment: | 600 |
| Study Start Date: | July 2008 |
| Estimated Study Completion Date: | January 2012 |
| Estimated Primary Completion Date: | January 2012 (Final data collection date for primary outcome measure) |
-
Behavioral: brief informational intervention to promote HPV vaccine acceptance
The HPV vaccine offers hope that the incidence of cervical cancer can be greatly reduced in the U.S. and globally. However, because the vaccine is recommended for children and early adolescents, vaccine awareness and acceptance among parents is critical to insuring vaccine uptake and public health benefit. Although culturally specific concerns may reduce HPV vaccination among African-American youth, research has not addressed this possibility. Accordingly, the proposed study will enroll 300 mothers in a study to identify barriers to HPV vaccination among low-income, African-American teens. Surveys assessing culturally-specific barriers to HPV vaccination acceptance will be administered to both parents and their vaccine-eligible children. Upon completion of the survey, parents with vaccine-eligible daughters will be invited to receive a free HPV vaccination for their child through a local, teen-friendly health clinic. Outcome analyses will focus on identification of predictors of completed vaccinations among girls and barriers to vaccine acceptance among mothers of teenage sons. Our study will provide critically important behavioral outcome data linking barriers to vaccination to subsequent vaccination decisions in a real-world, health care setting.
Eligibility| Ages Eligible for Study: | 11 Years and older |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
- Females parent or guardian with an African-American daughter or son between the ages of 11 and 17
- African-American adolescents between the ages of 11-17
Contacts and Locations| Contact: Peter A Vanable | 315-443-1210 | pvanable@syr.edu |
| United States, New York | |
| Center for Health and Behavior, Syracuse University | Recruiting |
| Syracuse, New York, United States, 13244 | |
| Contact: Rebecca Bostwick, MPA 315-443-9007 rabostwi@syr.edu | |
| Principal Investigator: Peter A Vanable, PhD | |
| Sub-Investigator: Michael P Carey, PhD | |
More Information
Additional Information:
No publications provided
| Responsible Party: | Peter A. Vanable, Associate Professor, Syracuse University |
| ClinicalTrials.gov Identifier: | NCT00680147 History of Changes |
| Other Study ID Numbers: | IISP ID# 33546 |
| Study First Received: | May 15, 2008 |
| Last Updated: | September 4, 2011 |
| Health Authority: | United States: Institutional Review Board |
Keywords provided by Syracuse University:
|
HPV Gardasil African-American adolescent |
health behavior sexually transmitted infections This will enroll 300 mothers of teenage girls and boys to identify barriers to HPV vaccination among low-income, African-American teens. |
ClinicalTrials.gov processed this record on May 21, 2013